COMMUNITY CLINICAL ONCOLOGY PROGRAM

罗切斯特大学癌症中心(URCC)，一家研究机构 在罗切斯特大学医学和牙科学院， 建议继续作为社区临床研究基地 肿瘤学计划(CCOP)申请机构。一项原创性研究 自1983年起服务于CCOP计划的基地，URCC/CCOP研究基地 已经进化并开发了相当多的癌症控制资源 研究活动。9项CCOP临床试验(5项癌症治疗 和四个癌症控制)已经开发，由NCI和 由我们研究基地的附属机构在当前拨款期间实施 更新。在每个州都注册了50多个癌症控制学分 在过去的两年里。 城市资源中心研究基地致力于建立一个 通过成员CCOP之间的协作促进协议开发 以及Out研究基地经验丰富的癌症控制专家， 以及癌症控制领域的顾问。这一竞争性更新将重点放在 浅谈开展和实施癌症控制工作的优势 研究作为大学癌症中心癌症控制研究基地 只有这样。我们目前提供六种NCI批准的癌症控制方案： 其中三项是检验有效性的随机干预试验 生物行为和药物干预在减少治疗中的作用 相关发病率。

The University of Rochester Cancer Center (URCC), a research institute within the University of Rochester School of Medicine and Dentistry, proposes to continue serving as a Research Base for Community Clinical Oncology Program (CCOP) applicant institutions. A original Research Base serving the CCOP program since 1983, the URCC/CCOP Research Base has evolved and developed considerable resources for cancer control research activities. Nine CCOP clinical trials (five cancer treatment and four cancer control) have been developed, approved by NCI and implemented by affliates of our Research Base during the current grant renewal. Over fifty cancer control credits have been registered in each of the past two years. The URCC Research Base is committed to a process and climate that fosters protocol development through collaboration among member CCOPs and affliates, experienced cancer control experts at out Research Base, and consultants in cancer control areas. This competing renewal focuses on strengths in the development and implementation of cancer control studies as a University Cancer Center Research Base for cancer control only. We currently offer six NCI approved cancer control protocols: three are randomized intervention trials that examine the effectiveness of biobehavioral and pharmacologic interventions in reducing treatment related morbidity.